| Literature DB >> 27557717 |
Daniela Ehgartner1,2, Jens Fricke1,2, Andreas Schröder1,2, Christoph Herwig3,4.
Abstract
Spore inoculum quality in filamentous bioprocesses is a critical parameter associated with viable spore concentration (1) and spore germination (2). It influences pellet morphology and, consequently, process performance. The state-of-the-art method to measure viable spore concentration is tedious, associated with significant inherent bias, and not applicable in real-time. Therefore, it is not usable as process analytical technology (PAT). Spore germination has so far been monitored using image analysis, which is hampered by complex medium background often observed in filamentous bioprocesses. The method presented here is based on the combination of viability staining and large-particle flow cytometry which enables measurements in real-time and hence aims to be applicable as a PAT tool. It is compatible with the complex media background and allows the quantification of metabolically active spores and the monitoring of spore germination. A distinction of germinated spores and not germinated spores was based on logistic regression, using multiparameteric data from flow cytometry. In a first step, a significant correlation between colony-forming unit (CFU) counts and viable spore concentration (1) in an industrially relevant model bioprocess was found. Spore germination (2) was followed over the initial process phase with close temporal resolution. The validation of the method showed an error below 5 %. Differences in spore germination for various spore inocula ages and spore inoculum concentrations were monitored. The real-time applicability of the method suggests the implementation as a PAT tool in filamentous bioprocesses.Entities:
Keywords: Filamentous fungi; Flow cytometry; Process analytical technology; Spore germination; Spore viability
Mesh:
Substances:
Year: 2016 PMID: 27557717 PMCID: PMC5035658 DOI: 10.1007/s00253-016-7787-y
Source DB: PubMed Journal: Appl Microbiol Biotechnol ISSN: 0175-7598 Impact factor: 4.813
Fig. 1Gate setting to discriminate FDA-positive spores (green circles) from media background and other spore sub-populations (blue crosses). The classification was done via intensities in FLY and FLO max (a) as well as via FWS and SWS total (b)
Fig. 2Correlation of FDA-positive spores and CFU counts. The slope of the linear fit was almost 1 with an R 2 of 0.97
Fig. 3FWS, SWS and FLY signals of a non-germinated (a) and a germinated spore (b)
Fig. 4Spores and hyphae in the flow cell. a Non-germinated spore. b Germinating spore. c Germinated spore. d Unbranched hyphae. e Branched hyphae
Estimated coefficients for two sensitivity levels
| FLY sensitivity level of 50 | FLY sensitivity level of 65 | |
|---|---|---|
|
| 28.31 | 29.01 |
|
| −0.337 | −0.346 |
|
| −0.184 | −0.106 |
|
| −0.006 | −0.001 |
|
| 54.05 | 40.35 |
|
| −59.54 | −52.44 |
Contingency table for the evaluation of the spore germination method for samples measured at FLY sensitivity level 65
| Cultivation time [h] | TP | FP | TN | FN | Total |
|---|---|---|---|---|---|
| 14 | 0 | 1 | 134 | 0 | 135 |
| 20 | 114 | 2 | 37 | 20 | 173 |
| 24 | 124 | 1 | 6 | 4 | 135 |
Shown are the numbers of true positive (TP, germinated spores which were classified as germinated spores), false positive (FP, germinated spores not categorized as germinated), true negative (TN, non-germinated spores categorized as non-germinated) and false negative (FN, non-germinated spores categorized as germinated). Furthermore, the total amount of investigated spores is shown. Samples of three different cultivation times were evaluated
Error of the method to monitor spore germination
| Cultivation time [h] | Error [%] | |
|---|---|---|
| Sensitivity level 50 | Sensitivity level 65 | |
| 14 | 4.2 | 0.7 |
| 20 | 2.6 | 7.5 |
| 24 | 3.7 | 3.7 |
Fig. 5Size distribution (a) and distribution of FLY (b) of round and germinated spores in batch 1. The number of spores is normalized to show the amount of spores per sampling point in percent
Fig. 6Spore germination over process time as percentage of total FDA-positive spore count. In batch 1 and 4, 90 % of the spores germinated. In the other two batches, the amount of germinated spores does not exceed 70 %